01-25821. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK.

    The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Diabetes and Digestive and Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.

    Date: November 28-30, 2001.

    Open: November 28, 2001, 6 PM to 6:30 PM.

    Agenda: Introductions and Overview.

    Place: National Institutes of Health, Building 5, Room 127, Bethesda, MD 20892.

    Closed: November 28, 2001, 6:30 PM to adjournment.

    Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

    Place: National Institutes of Health, Building 5, Room 127, Bethesda, MD 20892.

    Closed: November 29, 2001, 8 AM to adjournment.

    Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

    Place: National Institutes of Health, Building 5, Room 127, Bethesda, MD 20892.

    Closed: November 30, 2001, 8 AM to adjournment.

    Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

    Place: National Institutes of Health, Building 5, Room 127, Bethesda, MD 20892.

    Contact Person: Marvin C. Gershengorn, MD, Scientific Director, Division of Intramural Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bldg. 10, Rm. 9N222, Bethesda, MD 20892, (301) 496-4129.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93-849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

    Start Signature

    Dated: October 4, 2001.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 01-25821 Filed 10-12-01; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
11/28/2001
Published:
10/15/2001
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
01-25821
Dates:
November 28-30, 2001.
Pages:
52438-52438 (1 pages)
PDF File:
01-25821.pdf